228 related articles for article (PubMed ID: 17724025)
1. Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.
Zhang MM; Green BR; Catlin P; Fiedler B; Azam L; Chadwick A; Terlau H; McArthur JR; French RJ; Gulyas J; Rivier JE; Smith BJ; Norton RS; Olivera BM; Yoshikami D; Bulaj G
J Biol Chem; 2007 Oct; 282(42):30699-706. PubMed ID: 17724025
[TBL] [Abstract][Full Text] [Related]
2. Importance of position 8 in μ-conotoxin KIIIA for voltage-gated sodium channel selectivity.
Van Der Haegen A; Peigneur S; Tytgat J
FEBS J; 2011 Sep; 278(18):3408-18. PubMed ID: 21781281
[TBL] [Abstract][Full Text] [Related]
3. Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin.
Zhang MM; Gruszczynski P; Walewska A; Bulaj G; Olivera BM; Yoshikami D
J Neurophysiol; 2010 Jul; 104(1):88-97. PubMed ID: 20410356
[TBL] [Abstract][Full Text] [Related]
4. Interactions of key charged residues contributing to selective block of neuronal sodium channels by μ-conotoxin KIIIA.
McArthur JR; Singh G; McMaster D; Winkfein R; Tieleman DP; French RJ
Mol Pharmacol; 2011 Oct; 80(4):573-84. PubMed ID: 21709136
[TBL] [Abstract][Full Text] [Related]
5. Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.
Bulaj G; West PJ; Garrett JE; Watkins M; Zhang MM; Norton RS; Smith BJ; Yoshikami D; Olivera BM
Biochemistry; 2005 May; 44(19):7259-65. PubMed ID: 15882064
[TBL] [Abstract][Full Text] [Related]
6. μ-conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels.
Zhang MM; Han TS; Olivera BM; Bulaj G; Yoshikami D
Biochemistry; 2010 Jun; 49(23):4804-12. PubMed ID: 20459109
[TBL] [Abstract][Full Text] [Related]
7. Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB.
Wilson MJ; Zhang MM; Azam L; Olivera BM; Bulaj G; Yoshikami D
J Pharmacol Exp Ther; 2011 Aug; 338(2):687-93. PubMed ID: 21586605
[TBL] [Abstract][Full Text] [Related]
8. muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits.
Ekberg J; Jayamanne A; Vaughan CW; Aslan S; Thomas L; Mould J; Drinkwater R; Baker MD; Abrahamsen B; Wood JN; Adams DJ; Christie MJ; Lewis RJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):17030-5. PubMed ID: 17077153
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for the subtype specificity of μ-conotoxin SIIIA targeting neuronal voltage-gated sodium channels.
Leipold E; Markgraf R; Miloslavina A; Kijas M; Schirmeyer J; Imhof D; Heinemann SH
Neuropharmacology; 2011; 61(1-2):105-11. PubMed ID: 21419143
[TBL] [Abstract][Full Text] [Related]
10. Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons.
West PJ; Bulaj G; Garrett JE; Olivera BM; Yoshikami D
Biochemistry; 2002 Dec; 41(51):15388-93. PubMed ID: 12484778
[TBL] [Abstract][Full Text] [Related]
11. Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.
Khoo KK; Feng ZP; Smith BJ; Zhang MM; Yoshikami D; Olivera BM; Bulaj G; Norton RS
Biochemistry; 2009 Feb; 48(6):1210-9. PubMed ID: 19170536
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of the recombinant Phoneutria nigriventer Tx1 toxin on voltage-gated sodium channels.
Silva AO; Peigneur S; Diniz MR; Tytgat J; Beirão PS
Biochimie; 2012 Dec; 94(12):2756-63. PubMed ID: 22968173
[TBL] [Abstract][Full Text] [Related]
13. Synergistic and antagonistic interactions between tetrodotoxin and mu-conotoxin in blocking voltage-gated sodium channels.
Zhang MM; McArthur JR; Azam L; Bulaj G; Olivera BM; French RJ; Yoshikami D
Channels (Austin); 2009; 3(1):32-8. PubMed ID: 19221510
[TBL] [Abstract][Full Text] [Related]
14. Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.
Khoo KK; Wilson MJ; Smith BJ; Zhang MM; Gulyas J; Yoshikami D; Rivier JE; Bulaj G; Norton RS
J Med Chem; 2011 Nov; 54(21):7558-66. PubMed ID: 21962108
[TBL] [Abstract][Full Text] [Related]
15. μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve.
Wilson MJ; Yoshikami D; Azam L; Gajewiak J; Olivera BM; Bulaj G; Zhang MM
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10302-7. PubMed ID: 21652775
[TBL] [Abstract][Full Text] [Related]
16. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of Na(V)β subunits alters the kinetics of inhibition of voltage-gated sodium channels by pore-blocking μ-conotoxins.
Zhang MM; Wilson MJ; Azam L; Gajewiak J; Rivier JE; Bulaj G; Olivera BM; Yoshikami D
Br J Pharmacol; 2013 Apr; 168(7):1597-610. PubMed ID: 23146020
[TBL] [Abstract][Full Text] [Related]
18. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
19. A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors.
Favreau P; Benoit E; Hocking HG; Carlier L; D' hoedt D; Leipold E; Markgraf R; Schlumberger S; Córdova MA; Gaertner H; Paolini-Bertrand M; Hartley O; Tytgat J; Heinemann SH; Bertrand D; Boelens R; Stöcklin R; Molgó J
Br J Pharmacol; 2012 Jul; 166(5):1654-68. PubMed ID: 22229737
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and molecular basis for the sodium channel subtype specificity of µ-conopeptide CnIIIC.
Markgraf R; Leipold E; Schirmeyer J; Paolini-Bertrand M; Hartley O; Heinemann SH
Br J Pharmacol; 2012 Oct; 167(3):576-86. PubMed ID: 22537004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
